Categories
Pharmaceutical

Covid-19: Impact on Radiochemical Synthesizers Market Statistics 2021-2031: Innovation and Product Optimization to Boost Growth

Fact.MR has used a versatile approach to focus attention on the historical evolution, sales and demand of Radiochemical Synthesizers Market. Drivers and constraints, threats and opportunities, regional segmentation and opportunity assessment, end-use/application prospects review, and competitive landscape assessment are just a few of the topics addressed in the Global Radiochemical Synthesizers Market report.

Radiochemical synthesizers make chemical products which include small portions of radioisotopes by irradiating a selected target which are found inside a nuclear research reactor or in a particle accelerator. When such radioisotopes are produced, these are tagged on certain molecules based on biological capabilities which leads to Radiotherapy.

Request For Sample Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=5632

Competitive Landscape

Some of the major players in the global Radiochemical Synthesizers Market are Mercurius Health, IBA, Elysia, IAEA, Advion, Inc, Advanced Cyclotron Systems, JSC Isotope, Lantheus Medical Imaging, Inc., BV Cyclotron VU, LabLogic Systems Ltd, NorthStar Medical Technologies Technological advancement in already marketed products, which is the major trend emerging in the global Radiochemical Synthesizer Market.

Key Segments of Radiochemical synthesizers Market Covered in the Report

Based on Product, the global Radiochemical Synthesizers Market is segmented as:

  • Cyclotron
  • Nuclear Reactor
  • Radionuclide generator

Based on indications, the global Radiochemical Synthesizers Market is segmented as:

  • Cancer Treatment
  • Neurology
  • Cardiology

Based on end user, the global Radiochemical Synthesizers Market is segmented as:

  • Hospitals
  • Pharmaceutical Companies
  • Academic and Research centres

Request Customized Report as Per Your Requirements –

https://www.factmr.com/connectus/sample?flag=RC&rep_id=5632

Will the Market of U.S. is Larger than that of Asia?

The U.S. is holding largest share in the market attributing to the existence of a large population affected with chronic diseases like coronary disorders, cancer, unhealthy lifestyles, and increasing R&D for effective and reduced side effects treatment. As per the National Cancer Institute, in 2020, around 4.5 million cases of cancer were diagnosed in the US. The rise in the research & development (R&D) and the existence of the leading players in the market will boost the Radiochemical synthesizer’s market growth.

The Growing investment for research and the presence of a huge patient pool and the presence of developed economies such as Germany, the UK, and France are expected to drive the growth of the market. Europe is expected to be the second largest market after U.S.

Share Your Requirements & Get Customized Reports : https://www.factmr.com/checkout/5632

Report Benefits & Key Questions Answered

  • Radiochemical Synthesizers Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Radiochemical Synthesizers Historical volume analysis: The report provides a comparison of Radiochemical Synthesizers historical sales and projected sales performance for 2021-2031.
  • Radiochemical Synthesizers Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Radiochemical Synthesizers market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Radiochemical Synthesizers Consumption by demographics: The report investigates consumer behaviour affecting Radiochemical Synthesizers demand outlook for the assessment period. Effect of their keenness for digital trends on Radiochemical Synthesizers market is carefully analysed
  • Post COVID consumer spending on Radiochemical Synthesizers: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analysed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Radiochemical Synthesizers market growth.

Explore Fact.MR’s Coverage on the Healthcare Domain

Single-Dose Radiotherapy Market: Fact.MR’s ongoing research project on the single-dose radiotherapy market delves into detailed observations regarding the prominent expansion prospects expected to present themselves throughout the forthcoming decade.

Image Guided Radiotherapy Market: The global image guided radiotherapy market is likely to escalate to new heights, amid rising prevalence of various respiratory disorders, according to an ongoing study on the market by Fact.MR.

Radiotherapy Devices Market: Fact.MR’s incumbent study on the radiotherapy devices market brings to the fore important growth dynamics which are expected to shape future expansion trajectory for the decade until 2031.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

COVID-19 Impact on Lung Monitoring Devices Market Set for Rapid Growth and Trend, by 2031

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the Lung Monitoring Devices Market during the historical period. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2031, and key prospects over the forecast period 2021 – 2031. The insights and analytics on the Lung Monitoring Devices Market span several pages. These are covered in numerous sections, including, drivers and restraints, challenges and opportunities, regional segmentation and opportunity assessment, end-use/application prospects analysis, and competitive landscape assessment.

To get In-depth Insights Request for Free Brochure here : https://www.factmr.com/connectus/sample?flag=B&rep_id=5670

Respiration is an irreplaceable human life cycle, beginning at the time of birth and continuing up until death. For lots of years, a healthy body has actually had the ability to breathe, however due to increasing levels of contamination in cosmopolitan cities and way of lives including smoking, obstructing of respiratory tracts and other lung structures, it is ending up being an around the world concern.

Lung monitoring systems are devices that provide medication to prevent and handle signs and assistance reduce worsenings of several lung conditions such as persistent obstructive lung illness (COPD) and asthma. Lung monitoring devices might consist of either a single or a mix of drugs, such as a bronchodilator, a corticosteroid, a mix of various bronchodilator or corticosteroid respectively.

More than 1 billion individuals around the world are impacted by persistent breathing illness, based on the 2018 Global Asthma Survey. One of the primary factors to this fact is asthma, which impacts babies, grownups, and senior individuals.

Key Segments of Lung Monitoring Devices Market Covered in the Report

Based on type of device, the lung monitoring devices market has been segmented as:

  • Spirometers
  • Pulse Oximeters
  • Peak Flow Meters
  • Sleep Test Devices
  • Gas Analyzers
  • Capnographs
  • Other Types of Devices

Pre-Book Right Now for Exclusive Analyst Support: https://www.factmr.com/checkout/5670

Based on end user, the lung monitoring devices market has been segmented as:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Homecare Settings

Based on the region, the lung monitoring devices market has been segmented as:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=5670

Competitive Landscape Analysis

  • DeVilbiss Healthcare LLC
  • Koninklijke Philips N.V.
  • Vitalograph Ltd
  • ResMed Inc.
  • Haag-Streit group
  • Medline Industries Inc.
  • Trudell Medical International
  • Teleflex Inc.
  • Omron Healthcare Co Ltd.
  • Rossmax International Ltd.
  • Vyaire Medical Inc.
  • nSpire Health Inc.

Hence, the demand for smart peak flow meters can increase in the future, which can ultimately increase the growth of the lung monitoring devices market at a higher rate.

Read More Trending Reports of Fact.MR- https://www.biospace.com/article/melanoma-cancer-diagnostics-market-to-rely-on-fish-and-ai-for-future-expansion-fact-mr/

Explore Fact.MR’s Coverage on the Healthcare Domain:

 Next Generation Patient Monitoring Devices MarketThe global demand for next-generation patient monitoring devices witnessed major rise in Covid-19 pandemic due to the rising focus on health and well-being amongst the people in 2020.

Continuous Cardiac Monitoring Systems Market- Continuous cardiac monitoring systems market is estimated to observe a slight increase in demand amid pandemic with an increasing number of Covid 19 patients.

Ambulatory heart Monitor Market- The global ambulatory heart monitor market is anticipated to grow with the rising cardiovascular diseases, expanding geriatric population, high demand for ambulatory heart monitors for its utility, efficacy and cost-effectiveness and technological enhancements.

 About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

 Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Lip Filler Market Share to Gain a Stronghold during Forecast Period Till 2026

Fact.MR, a global research firm, in its recent report on the global lip filler market shall register a steady CAGR in 2021 & beyond. Rise in number of aesthetic procedures and increasing payment options to boost the aesthetic procedure pace are contributing to the expansion of the industry. Also, improvements in the preparation procedure of lip fillers have prompted a higher need for lip procedures.

The market survey of Lip Filler offers a comprehensive analysis of diverse features, including production capacities analysis of Lip Filler, demand, product developments, revenue generation, and sales of Lip Filler across the globe.

For detailed insights on enhancing your product footprint, request for a brochure here: https://www.factmr.com/connectus/sample?flag=B&rep_id=864

Competitive Landscape Analysis

 Some of the key players are Mentor Worldwide LLC, Anika Therapeutics Inc., Allergan Plc, and Inamed Corporation, etc.

The growing investments in research and development of cosmetic industry have been encouraging the prominent players to offer effective solutions to gain a competitive edge.

 Merz Aesthetics: The prominent player in lip filler market, Merz Aesthetics launched a new a lip filler with hyaluronic acid called Belotero lips in April 2018.

  • Galderma: The Pharmaceutical Company launched two new dermal fillers last year. In December 2016, Galderma got FDA approval for: Restylane Refyne and Restylane Defyne, its two next-generation hyaluronic acid (HA) dermal fillers. The brand calibrated the products for smoothness and consistent textures, delivering dual benefit of flexibility and distributed product integration.

Segmentation:

The global market for lip filler can be classified on the basis of product type, and end users. By product type, it can be bifurcated into Hyaluronic Acid based products, and Collagen based products, whereas, in terms of end users, the market can be segmented into hospitals and specialty clinics.

Request Customized Report as Per Your Requirements –

https://www.factmr.com/connectus/sample?flag=RC&rep_id=864

Key Developments in Lip Filler Market

In November 2020, Aesthetic innovations announced its partnership with Merz Aesthetics to launch National Xeomin Campaign for their new product line, Xeomin. The development is a mobile video technology that records the customer’s end to end experience. The company is looking forward to customise and improve customer experience via mobile video without apps, or logins or email, etc.

Suneva medical in May 2020 announced that it is all set to increase its partnership and leadership in aesthetic with Sinclair Pharma’s new launch, Silhouette Instalift. The launch is likely to address the growing demand for natural alternatives in aesthetics. The product provides immediate lift to sagging cheeks and activates the patient’s natural collagen production over time.

Pre-Book Right Now for Exclusive Analyst Support: https://www.factmr.com/checkout/864

A Switzerland based company Gladerma in May 2020 announced the results of their newly launch treatment DREAM (Dysport Real- World Evaluation and Measured satisfaction study). The treatment is 95% efficient with two treatments per year and 97% of patients felt the look natural after treatment. Dysport is an injection for removing the severe frown lines between the eyebrows in adults aging less than 65 years.

Social media is overflowing with airbrushed pictures of celebrities with perfectly groomed bodies staged in exotic locations, and such impeccable photographs are pressurizing youngsters to meet unattainable body-image standards. In the race to look flawless, growing number of people are spending on cosmetic treatments like lip fillers, Botox etc.

Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2020/03/03/1994330/0/en/Sterile-Active-Pharmaceutical-Ingredients-Market-Set-for-Robust-Growth-Through-2029-Injectable-Drugs-in-Demand-Reports-a-Fact-MR-Study.html

Explore Fact.MR’s Healthcare Reports

Hospital Asset Management Market: Delve into Fact.MR’s extensive study on the hospital asset management market, offering detailed assessment. The study analyses crucial trends that are currently determining, and those which are expected to shape future expansion trajectory, shedding light on the vital dynamics such as drivers, restraints and opportunities.

Aneurysm Clips Market: The global aneurysm clips market study published by Fact.MR incorporates detailed assessment of the market landscape, taking into consideration value chain analysis, business execution and supply chain analysis across key markets.

Aptamers Market: Fact.MR’s global aptamers market research report provides stakeholders with an exhaustive analysis on key market dynamics, such as the drivers, restraints, opportunities and trends responsible for shaping the future expansion trajectory.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

North America Accounting for 34% of the Upper Extremity Prosthetics Market Share by 2025

Fact.MR, in its exclusive research report on the artificial limbs market, highlights actionable insights and winning imperatives for stakeholders.

This comprehensive study unfolds rare and distinguished intelligence regarding impactful dynamics, which directly or indirectly influence the growth of artificial limbs during the forecast period (2020 – 2025).

With the help of crucial insights discussed in this study, stakeholders will gain a thorough idea regarding the growth trajectory of the artificial limbs market.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4359

Mind-controlled humonic solutions are a radical breakthrough in research related to artificial limbs. These solutions can restore the unmet needs of lost sensation and human-like aesthetics, including gestures and volitional control. Extensive research in the field of artificial intelligence aimed at better quality of life for amputees is fuelling the growth of the artificial limbs market. Fact.MR, in its newest report, reveals that, the Sales of artificial limbs is all set to witness a healthy CAGR of 6% through the forecast period (2020 – 2025).

Artificial Limbs Market – Assessment of Key Segments

Product
  • Upper Extremity
  • Lower Extremity
  • Sockets
  • Liners
  • Others
Technology
  • Cosmetic Prosthetics
  • Cable-operated/Battery-powered Prosthetics
  • Electrically-powered/Myoelectric Prosthetics
End User
  • Hospitals
  • Prosthetic Clinics
  • Rehabilitation Centres
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Get Customization on this Research Report for specific research solutions:

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4359

Key Takeaways of Artificial Limbs Market

• Lower extremity prosthetics accounted for 55% share of the market in 2019, owing to the high prevalence of diabetes and vascular diseases across the globe.
• Electrically-powered/myoelectric prosthetics are projected register the fastest growth by the end of the forecast period. Advancements such as multi-articulating myoelectric hands are estimated to fuel this growth.
• According to Fact.MR, hospitals and prosthetic clinics will collectively account for 75% of the market share by the end of the forecast year. An uptick in the demand for prosthetics for trauma injuries and amputations during military combat will bolster the growth of these segments.
• North America will lead the artificial limbs market by the end of the forecast period. However, Asia Pacific will witness prolific growth, on the back of a surging geriatric population and an alarming high incidence of accidents.

For information on the Research Approach used in the Report, Request Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4359

artificial limbs market regional opportunity assessment

“Clinical service networks, strong clinical teams, high focus on the marketing of products, and market diversification will be the key tenets of success for market players operating in the artificial limbs market”, says a Fact.MR Analyst.

Product Innovations and Well-timed Partnerships Lead to a Top-Heavy Competition Landscape
The artificial limbs market is highly consolidated in nature, with Ossur, Ottobock, and Hanger among the key players. Leading players have established a strong foothold in the market through strong teams, innovation, a highly-nuanced product portfolio, and timely acquisitions. For instance,
• In November 2019, Ossur and Alfred Mann Foundation (AMF) signed a milestone agreement that allows Ossur to further develop and licence AMF’s implanted myoelectric sensor systems, as both these organizations surge ahead to explore the potential of mind-controlled prosthetic technologies.
• In the same month, Ottobock announced advancements in upper limb prosthetics, called the Myo Plus pattern recognition system. Ottobock partnered with Hanger to fit this new design onto an amputee. The technology has been approved and cleared by the FDA.

Fore More Insights

https://www.biospace.com/article/cell-proliferation-market-players-are-relying-on-partnerships-and-alliance-to-speed-up-r-and-d-study/

Key Players 

  • Össur
  • Hanger, Inc.
  • Ohio Willow Wood Company
  • Ottobock
  • RSL Steeper Group Ltd.
  • PROTEOR
  • Blatchford Group
  • Liberating Technologies, Inc.
  • Fillauer LLC
  • Spinal Technology, Inc.
  • Optimus Prosthetics

Find More Valuable Insights on Artificial Limbs Market

The research study on the artificial limbs market by Fact.MR incorporates an unbiased assessment of the key demand-driving factors and trends that can shaped the landscape of artificial limbs over 2020 – 2025, and includes a detailed assessment of the key parameters that are anticipated to exert influence over the forecast period. Market statistics have been presented on the basis of product (upper extremity, lower extremity, sockets, liners, others), technology (cosmetic prosthetics, cable-operated/body-powered prosthetics, electrically-powered/myoelectric prosthetics, others), end user (hospitals, prosthetic clinics, rehabilitation centres), across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Understanding COVID-19’s impact on Implantable Pump Catheter Market 2028 expected to grow faster with key winning strategies

The latest research report published by Fact.MR (Leading business and competitive intelligence provider) on the Survey of Implantable Pump Catheter Market is intended to offer reliable data on various key factors shaping the Implantable Pump Catheter growth curve & outlook of Implantable Pump Catheter market.

The Demand analysis of Implantable Pump Catheter offers a comprehensive analysis of diverse features, including production capacities And Market analysis of Implantable Pump Catheter, demand, Survey, product developments, revenue generation, and sales of Implantable Pump Catheter Market across the globe.

To get In-depth Insights Request for Brochure Here – https://www.factmr.com/connectus/sample?flag=B&rep_id=861

 Pulmonary Hypertension Emerging as a Global Health Issue

Pulmonary hypertension is a rapidly growing issue, especially among elderly population and in countries with the rise in aging population. The increasing pervasiveness of Pulmonary Arterial Hypertension (PAH) and a growing number of cases globally are driving demand for implantable pump catheter facilitating catheter implantation during treatment of PAH.

Researchers have also found Methamphetamine abuse leading to PAH. The US accounts for the maximum number of methamphetamine-related PAH patients. A significant drop in the blood stream infection is driving the demand for implantable pump catheter in PAH treatment.

Implantable Pump Catheter Market Segmentation:

Based on the end-user, the market is segmented into,

  • Ambulatory Surgical Centers
  • Hospitals
  • Others

For in-depth competitive analysis, buy now : https://www.factmr.com/checkout/861

Report Benefits & Key Questions Answered

  • Implantable Pump Catheter Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Implantable Pump Catheter Historical volume analysis: The report provides a comparison of Implantable Pump Catheter historical sales and projected sales performance for 2021-2031.
  • Implantable Pump Catheter manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Implantable Pump Catheter market. It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Implantable Pump Catheter Consumption by demographics: The report investigates consumer behaviour affecting Implantable Pump Catheter demand outlook for the assessment period. Effect of their keenness for digital trends on Implantable Pump Catheter market is carefully analysed
  • Post COVID consumer spending on Implantable Pump Catheter: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analysed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Implantable Pump Catheter market growth.

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=861

Implantable Pump Catheter Market- Regional Outlook

North America is expected to hold a strong position in the implantable pump catheter market followed by Europe. US is likely to witness robust growth in the market due to the presence of well-established medical device companies, generating a majority of its sales from the US healthcare system. Japan is also expected to see healthy growth in the coming years owing to the rise in government spending on healthcare.

Read More Trending Reports of Fact : https://www.biospace.com/article/is-pcr-market-moving-toward-personalized-medicine-new-study-explores/

 Explore Fact.MR’s Coverage on the Healthcare Domain:

Anti-Snoring Treatment Market According to the latest research by Fact.MR., the anti-snoring treatment market is set to witness steady growth during 2021-2031.

Artificial Retina Market According to the latest research by Fact.MR., the artificial retina market is observed steady growth during 2021-2031.

Brain Implant Market According to latest research by Fact.MR., brain implants market is observer stead growth during 2021-2031.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

E-Mail: sales@factmr.com

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Categories
Pharmaceutical

Brain Tissue Oxygen Monitoring Systems Market Projected to Grow faster according to a new research report Up to 2028

The rising incidence and cases of brain diseases and disorders such as traumatic brain injury (TBI), strokes and others, coupled with the high demand for the brain tissue oxygen monitoring systems are the prime drivers of brain tissue oxygen monitoring system market.

Fact.MR’s ongoing survey of clinical EHR systems market study forecasts a strong growth trajectory for the FY 2021-22, building upon the already prevailing upward trend since 2020 in the midst of heavy reliance on digital platforms to cope with the coronavirus pandemic crisis. Future adoption is only expected to incline, ushering in a healthy growth pattern through 2028.

To Remain ‘Ahead’ Of Your Competitors, Request For A Broucher: https://www.factmr.com/connectus/sample?flag=B&rep_id=2292

Brain Tissue Oxygen Monitoring Systems Market: Drivers and Restraints

The rising incidence and cases of brain diseases and disorders such as traumatic brain injury (TBI), strokes and others, coupled with the high demand for the brain tissue oxygen monitoring systems are the prime drivers of the brain tissue oxygen monitoring system market. According to the Centers for Disease Control and Prevention (CDC), about 2.8 million TBI-related hospitalisations and deaths occurred in the U.S. in 2016, which amounted to 50,000 deaths. The CDC data also reveals an astonishing increase in TBI-related hospitalisations, which grew by 47% during a span of six years from 2010 to 2016.

The measurement of oxygen partial pressure in the brain is critical to the prognosis and treatment of patients as there is no definitive curative treatment for brain trauma, which is the clinical driver of the brain tissue oxygen monitoring systems market. Brain oxygen is a key parameter of mortality in traumatic brain injury as even small periods of hypoxia and hypotension can significantly boost mortality. Thus the low elasticity of demand for brain tissue oxygen monitoring systems is expected to propel the brain tissue oxygen monitoring systems market to attractive growth.

Pre-Book Right Now for Exclusive Analyst Support: https://www.factmr.com/checkout/2292

Brain Tissue Oxygen Monitoring Systems Market: Segmentation

The global brain tissue oxygen monitoring systems market is segmented based on mechanism, distribution channel and region.

Based on mechanism, the global brain tissue oxygen monitoring systems market is segmented into:

  • Clark electrode technology
  • Fluorescence and Fiberoptic luminescence quenching technology

Based on portability, the global brain tissue oxygen monitoring systems market is segmented into:

  • Non-portable
  • Portable

Based on end user, the global brain tissue oxygen monitoring systems market is segmented into:

  • Hospitals
  • Neurology clinics
  • Ambulatory Care Centres

Request Customized Report as Per Your Requirements – https://www.factmr.com/connectus/sample?flag=RC&rep_id=2292

Brain Tissue Oxygen Monitoring Systems Market: Key Players
Some of the major vendors operating in the global brain tissue oxygen monitoring systems market are Integra LifeSciences Corporation; Hamamatsu Photonics K.K.; Medtronic; Scintica Instrumentation, Inc.; CARDION s r.o.; Oxford Optronix Ltd., RAUMEDIC AG among others.
Important doubts related to the Brain Tissue Oxygen Monitoring Systems Market clarified in the report:

  1. Which regional market is expected to witness the highest growth during the forecast period?
  2. How has the surging prices of raw materials during the COVID-19 pandemic impacted the growth of the keyword market?
  3. Why are market players focusing on R&D and innovations?
  4. Are market players expanding their global presence? If yes, how?

Read More Trending Reports of Fact.MR : https://www.globenewswire.com/en/news-release/2020/03/05/1995769/0/en/Premium-Brands-Pushing-Whiskey-Market-Prospects-through-2029-Blended-Grain-Whiskeys-to-Remain-Top-Selling-Projects-a-New-Fact-MR-Study.html

Explore Fact.MR’s Coverage on the Healthcare Domain:

Lung Monitoring Devices MarketThe research report on lung monitoring devices market provides facts, thoughtful insight and market-validated data.

Brain Implant MarketDemand for brain implant expects to witness steady recovery in the short-term, with an optimistic growth outlook in the long run.

Tissue Microarrayer Market- Tissue microarrayer Market is anticipated to flourish in the field of cancer research as they are used in the analysis and validation process of cancer biomarkers.

About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:

11140 Rockville Pike

Suite 400

Rockville, MD 20852

United States

Tel: +1 (628) 251-1583

Corporate Headquarter:

Unit No: AU-01-H Gold Tower (AU),

Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers,

Dubai, United Arab Emirates

Email: sales@factmr.com

Visit Our Website: https://www.factmr.com

Categories
Pharmaceutical

Demand for Topical Arthritis Therapeutics Is Estimated to Grow 1.5X During the Forecast Period (2020 – 2027)

Weighing the impact of key influencers, a recent report published by Fact.MR infers that, the Demand for arthritis therapeutics is estimated to grow 1.5X during the forecast period (2020 – 2027).

Rapid emergence of biologics presents new commercial opportunities for players in the arthritis therapeutics market. The adoption of biologic drugs is high, especially in developed countries of North America, Europe, and Asia Pacific, given the influence of favourable reimbursement scenarios that cushion the high cost.

In North America and Europe, the presence of public and private medical insurance plans encourages patients to avail quality healthcare. However, in developing countries of Asia Pacific, the out-of-pocket payment model is dominant in the healthcare industry, which is leading to sluggish growth of the arthritis therapeutics market in India and China. In addition, the penetration of generic drugs is high in developing countries of Asia Pacific, owing to their competitive prices.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4355

A key opinion leader at Fact.MR portends,“Demand for interleukin inhibitors is outperforming TNF inhibitors in terms of efficacy. In future, with effective marketing efforts by manufacturers, patients will turn more receptive to these novel biologic products.”

A comprehensive study published by Fact.MR projects the arthritis therapeutics market to register 7.3% growth in 2020, over 2019.

Arthritis Therapeutics Market – Assessment of Key Segments

Type
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Arthritis
  • Gout
  • Others
Drug Class
  • TNF Inhibitors
  • Interleukin Inhibitors
  • NSAIDS
  • Corticosteroids
  • Xanthine Oxidase Inhibitors
  • Others
Route of Administration
  • Oral
  • Parenteral
  • Topical
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Get Customization on this Research Report for specific research solutions: 

https://www.factmr.com/connectus/sample?flag=RC&rep_id=4355

Key Takeaways of Arthritis Therapeutics Market Study

• Constant rise in the prices of popular drugs such as Humira and Enbrel could shift the focus of patients towards complementary and alternative therapies, thereby narrowing the growth of the arthritis therapeutics market. The impact of this trend will be relatively high in developing countries of Asia Pacific such as India and China, as these regions are characterized by high inclination towards natural and herbal therapies.
• Patent expiration of blockbuster drugs in the arthritis therapeutics market are pushing manufacturers to increase investments towards the development of effective drugs, which is projected to fuel the advancements of biosimilar products.
• High precision of drugs offered by arthritis therapeutics is projected to maintain patients’ inclination towards parenteral route of administration during the forecast period.
• In 2020, retail pharmacies are projected to account for 79% of the total sales of arthritis therapeutics, as the high concentration of this channels across key locations makes it convenient for patients to purchase the required drugs. However, sales through online pharmacies will gain traction, owing to attractive discounts and convenience offered.

For information on the Research Approach used in the Report, Request Methodology  https://www.factmr.com/connectus/sample?flag=RM&rep_id=4355

A key opinion leader at Fact.MR portends, “Demand for interleukin inhibitors is outperforming TNF inhibitors in terms of efficacy. In future, with effective marketing efforts by manufacturers, patients will turn more receptive to these novel biologic products.”

R&D Remains Key Strength of Global Players; Regional Players Excel through Robust Distribution Networks

The arthritis therapeutics market, characterized by consolidation, is dominated by AbbVie Inc., Johnson & Johnson, Amgen Inc., and Novartis Inc. Development of blockbuster drugs enables these leading players to gain an edge over regional and local players. For instance, 33% of share in the arthritis therapeutics market accounted by AbbVie is attributable to its flagship product – Humira, which recorded sales corresponding to a value of US$ 20 Bn in 2018.

On similar lines, Johnson & Johnson strives to diversify its product portfolio through the introduction of effective therapeutics. The company is highly recognized for the launch of Simponi, Tremfya, and Stelara. Distribution channels remain the key strength of regional players. For instance, Eli Lily and Company offers most of its products around the world, and executes effective marketing strategies to position its products in various countries to meet unmet local needs.

Find More Valuable Insights on Arthritis Therapeutics Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global arthritis therapeutics market, presenting historical demand data (2017-2019), and forecast statistics for the period of 2020-2027. The study divulges compelling insights on the arthritis therapeutics market on the basis of type (rheumatoid arthritis, gout, psoriatic arthritis, osteoarthritis, and others), drug class (TNF inhibitors, interleukin inhibitors, NSAIDs, corticosteroids, xanthine oxidase inhibitors, and others), route of administration (parenteral, topical, and oral), and distribution channel (online pharmacies, hospital pharmacies, and retail pharmacies), across five major regions.

For More Insights

https://www.biospace.com/article/tracheostomy-tray-market-players-are-following-stringent-regulations-to-design-superior-tracheostomy-trays-opines-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Applications of Apheresis Procedures In Neurology are Projected to Show a Significant Rise : Fact.MR

Recent shift from single dose to double dose apheresis is indicative of the high demand for apheresis procedures among patients suffering from chronic diseases. Leading industry players are taking calculated growth measures to expand the application of the therapeutic apheresis procedure, which is currently used as the first line and supportive therapy in the treatment of over 87 diseases, as found by the American Society for Apheresis (ASFA). However, lack of availability of donors and concerns regarding histocompatibility could create negative sentiments among patients, inadvertently impeding revenue potential of the apheresis market to a certain extent. Defying all odds though, the apheresis market is projected to progress at an impressive CAGR of ~10% during the forecast period (2020 – 2025), as noted by Fact.MR in its latest study on the market.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4352

Market Segmentation

End User
  • Hospitals
  • Blood Collection Centres
    • Public
    • Private
Technology
  • Centrifugation
  • Membrane Filtration
Procedure
  • Plasmapheresis
  • Photopheresis
  • LDL Apheresis
  • Plateletpheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Others (Lymphapheresis and extracorporeal immunoadsorption)
Application
  • Renal Diseases
  • Neurology
  • Haematology
  • Cancer
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Others (Fibrosis and Diabetes)
Product
  • Devices
  • Disposables
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East &Africa

Key Takeaways of Apheresis Market Study

• Double dose apheresis is projected to gain prominence as the standard apheresis procedure in developed countries such as the U.S. Japan, and Germany, given an increase in awareness regarding apheresis procedures, competent plasma separator systems, and favourable reimbursement scenarios.
• Low availability of skilled professionals to perform apheresis procedures, in turn, increases the cost of operations, which could encourage patients to seek alternative treatments. This factor will be more impactful in economically-backward and developing regions, wherein, healthcare quality is still not at par with global standards.
• The popularity of plasmapheresis will remain high through 2027, on the backdrop of the high demand for plasma from pharmaceutical and biotechnology industries for the development of novel therapeutics.
• Applications of apheresis procedures in neurology are projected to show a marginal rise during the forecast period, as these procedures are recommended as the first line of treatment for neurological diseases such as Guillain-Barre syndrome (GBS), chronic focal encephalitis, multiple myeloma, and myasthenia gravis.

For information on the Research Approach used in the Report, Request Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4352

key segments in apheresis market

“Increasing prevalence of leukaemia and autoimmune disorders among children unfolds a new demography for players to cater to in the apheresis market, as a majority of apheresis therapies are only available for adult patients”, opines a senior market consultant at Fact.MR.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/4352

High Entry Barrier in Apheresis Market; Competition Continues to Intensify

The competition is high in the apheresis market, and is likely to intensify in the future, as the number of centres offering apheresis procedures is increasing. Cost-competitiveness remains a key strategy to maintain or increase share in the apheresis market. Existing players will witness low competition from new market entrants, as these players are well-established in the apheresis market with sound financial reserves, which enables them to easily scale their position. On the other hand, an entry into the apheresis market means high level of investment, sound technical knowledge, and licensing requirements, which is creating entry barriers for new players.

The current strategy of players in the apheresis market involves a scramble towards the Asia Pacific and Latin American markets. Besides inorganic growth, players seek market success by maintaining high research & development standards to target multiple applications through their products.

For More Insights

https://www.biospace.com/article/demand-for-micro-bypass-systems-bolstered-by-increasing-patients-undergoing-cataract-surgery-opines-fact-mr/

Find More Valuable Insights on Apheresis Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global apheresis market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the apheresis market on the basis of end user (hospitals and blood collection centres), technology (centrifugation and membrane filtration), procedure (plasmapheresis, photopheresis, LDL apheresis, plateletpheresis, leukapheresis, erythrocytapheresis, and others), product (devices and disposables), and application (renal diseases, neurology, haematology, cancer, autoimmune diseases, cardiovascular diseases, and others), across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Top 10 Breast Cancer Drugs Market KeyPlayers – Industry Outlook, Size, Share, Growth Prospects

250 Pages Anticancer Drugs Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider

Subtitle –Fact MR analysis of anticancer drugs market provides compelling insights into the factors propelling sales prospects in key segments such as (Drug type), (Therapy ), and (Cancer type ). (Region). It provides an executive-level blueprint of key market players’ strategies and analyses their impact on overall growth projections.

According to Fact MR’s recent market research, anticancer drugs sales will increase at  ~7% CAGR by 2025, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.

Focus on improving overall patient care will remain a chief growth driver. Besides this, anticancer drugs market will continue gaining from increasing willingness among patients and families to spend on advanced healthcare.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4350

To offer an in-depth overview, the report provides sales projections for over 20 countries. It also identifies segments exhibiting maximum growth potential on the basis of (Drug type), (Therapy ), (Cancer type ) and (Region).

Digital Transformation in Healthcare Presenting Opportunities for anticancer drugs market Growth

Healthcare organizations around the world are deploying digital tools to accommodating changing consumer preferences. They are pressing on solving the long-standing challenge pertaining to care model innovation.

Considering this, the focus on making healthcare affordable and more transparent will increase. Adoption of care model innovation in healthcare will have a profound impact on the Anticancer Drugs market.

Key Anticancer Drugs Survey Highlights and Projections

  • Despite COVID-19 outbreak causing enormous strain in the healthcare sector, the anticancer drugs market valuation is expected to total US$ 156 anticancer drugs bn by 2025.
  • Driven by higher investment in innovation, the U.S. will emerge as the dominant Anticancer Drugs market in North America, accounting for 7% of overall sales registered in 2021.
  • Growing awareness regarding cancer prevention and treatment, on the back of campaigns run by government organizations and NGOs across the world, is projected to encourage people to undergo screening tests.
  • With the presence of some of the world’s leading healthcare companies, coupled with high spending on hospital services, the U.K. and Germany will emerge as highly lucrative pockets in Europe.
  • Investment towards healthcare sector expansion and focus on medical tourism will make China, Japan, and South Korea key markets within East Asia.

Access Research Methodology Prepared By Experts –https://www.factmr.com/connectus/sample?flag=RM&rep_id=4350

Report Benefits & Key Questions Answered

  • Anticancer Drugs Category and segment level analysis: Fact MR provides a detailed analysis of the factors influencing sales growth across key segments. It highlights key growth drivers and provides useful information for identifying sales prospects at the regional and local level.
  • Anticancer Drugs Historical volume analysis: The report provides a comparison of Anticancer Drugs ‘s historical sales and projected sales performance for 2020-2025.
  • Anticancer Drugs Manufacturing trend analysis: The report offers a detailed analysis of manufacturing trends in the Anticancer Drugs It carefully gauges the impact of changing healthcare needs of key demographics globally
  • Anticancer Drugs Consumption by demographics: The report investigates consumer behavior affecting Anticancer Drugs demand outlook for the assessment period. Effect of their keenness for digital trends on Anticancer Drugs market is carefully analyzed
  • Post COVID consumer spending on Anticancer Drugs: Healthcare industry has been largely influenced by COVID-19 pandemic. The Fact MR Market survey analyzed consumer spending post COVID-19. It assesses how current trends that will influence expenditure on healthcare services, thus affecting Anticancer Drugs market growth.

key regions in anticancer drugs market

Competitive Landscape Analysis

The study offers insights into key trends affecting healthcare industry, subsequently influencing demand supply forces in the anticancer drugs market. To study competitive trends, it profiles some of the leading market players profiling leading players including AstraZeneca, Takeda Pharmaceutical Company Limited ,Merck & Co., Inc. , Amgen Inc, CELGENE CORPORATION.

To offer an in-depth analysis of prevailing competition, the report offers a detailed market share analysis. In this chapter market players are segregated in terms of  Tier 1, Tier 2, and Tier 3 companies. Strategies adopted by players across these categories and impact of the same on the overall market are studied at length.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4350

Anticancer Drugs Demand Analysis by Category

Drug Type

  • Targeted Drugs
  • Cytotoxic Drugs
  • Hormonal Drugs

Therapy

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Others

Cancer Type

  • Lung Cancer
  • Breast Cancer
  • Leukemia
  • Colorectal Cancer
  • Others

Region

  • North America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

For More Insights

https://www.biospace.com/article/laryngeal-papillomatosis-treatment-growth-fuelled-by-increasing-paitent-pool-of-laryngeal-papillomatosis-says-fact-mr/

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Website: https://www.factmr.com

 

Categories
Pharmaceutical

E-Pharmacies Emerging as Full-fledged Distribution Channel for Quinolones Antibacterial Drugs: Fact.MR

As per a recently published Fact.MR study, the Demand for antibacterial drugs is expected to surge to ~US$ 51 Bn by the end of the year 2025Patent expirations of blockbuster drugs are further offering ground to regional and local players to introduce generic drugs, which is hard-hitting the sales of branded drugs. However, rise in public-private funding is projected to underpin the development of novel drugs, thereby strengthening the pipeline for new therapeutics in the antibacterial drugs market. On the backdrop of these influences, a recently published report by Fact.MR portends that, the antibacterial drugs market will expand at a sluggish CAGR of 1.5% during the forecast period (2020-2025).

A senior research consultant at Fact.MR foresees,“Numerous branded drugs are on the verge of patent expiry, and there are less number of antibacterial drugs in the pipeline. Regional and local players are developing generic drugs in large quantities to bridge the demand-supply gap, which may lead to low RoI for leading players in the antibacterial drugs market.

Request a report sample to gain comprehensive market insights

https://www.factmr.com/connectus/sample?flag=S&rep_id=4340

Antibacterial Drugs Market – Assessment of Key Segments

Drug Class
  • ß-lactams
  • Quinolones
  • Macrolides
  • Tetracycline
  • Aminoglycosides
  • Sulfonamide
  • Phenicols
  • Others
Route of Administration
  • Enteral
  • Parenteral
  • Others (Inhalation, Topical, etc.,)
Distribution Channel
  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Sales
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Asia Pacific

For information on the Research Approach used in the Report, Request Methodology

https://www.factmr.com/connectus/sample?flag=RM&rep_id=4340

Key Highlights of Antibacterial Drugs Market Study

• Macrolides are fast-replacing quinolones, on the back of their high efficiency; however, the growing use of β-lactam in parallel to a large number of pipeline drugs in the phase-3 trial stage is expected to retain the lead of this drug class during the forecast period.
• Convenience remains a key determiner when it comes to preferred route of administration. Patients’ proclivity for enteral drugs is projected to increase, on account of oral therapy and relatively safe use than the parenteral route of administration.
• Currently, e-pharmacies witness challenges, such as non-complacency of e-retailers with government regulations, concerns regarding credibility of prescription, drug counterfeiting, and delay in shipping. However, in the future, this distribution channel will remain integral in driving sales from overseas markets.
• Wide availability of over-the-counter (OTC) drugs and generic drugs could limit the penetration of drugs in the Asia Pacific antibacterial drugs market. However, patent expiration of drugs in North America and Europe will also lead to a shift from branded drugs to generic ones, which could prevent the antibacterial drugs market from realizing its true revenue potential.

A senior research consultant at Fact.MR foresees, “Numerous branded drugs are on the verge of patent expiry, and there are less number of antibacterial drugs in the pipeline. Regional and local players are developing generic drugs in large quantities to bridge the demand-supply gap, which may lead to low RoI for leading players in the antibacterial drugs market.

Manufacturers Experiment with Route of Administration to Enhance Drug Efficiency

The antibacterial drugs market represents a fragmented landscape, wherein, Bayer AG, Pfizer Inc., Merck Co., Inc., Allergan Inc., and GlaxoSmithKline PLC occupy leading positions. Pharmaceutical companies are experimenting with the route of administration to enhance the effectiveness of drugs. For instance, the Amikacin inhaler is available as a nanoscale liposomal formulation, which is effective for the treatment of chronic P. aeruginosa lung infections in cystic fibrosis.

Full Access of this Report is Available At

https://www.factmr.com/checkout/4340

Besides this, the governments of numerous countries, especially developed countries, are playing an active role in empowering drug manufacturers to introduce new formulations. An example of this can be taken from the CDER Antibacterial Drug Development Task Force created by the U.S. Food and Drug Administration. The foundation of this unit lies in extending government support towards the development of new antibacterial drugs.

Collaborations of players in the antibacterial drugs market with academia, biotech companies, regulatory authorities, and pharmaceutical companies are also seen as a strategic move to gain the reciprocal advantage of technology and expertise.

  • Bayer AG
  • Pfizer Inc.
  • Sanofi
  • GlaxoSmithKline plc
  • Merck & Co., Inc
  • AstraZeneca
  • Johnson and Johnson
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Allergen Plc.

Following Questions Answers Covered in the Report are:

  • How will the global antibacterial drugs market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global antibacterial drugs market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global antibacterial drugs market?
  • How will these strategies influence the market growth and competition?

For More Insights

https://www.biospace.com/article/cephalic-disorders-treatment-market-players-are-seeking-partnership-with-large-organizations-and-hospitals-says-fact-mr

Find More Valuable Insights on Antibacterial Drugs Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global antibacterial drugs market, presenting historical demand data (2015-2019), and forecast statistics for the period of 2020-2025. The study divulges compelling insights on the antibacterial drugs market on the basis of drug class (β-lactams, quinolones, macrolides, tetracycline, aminoglycosides, sulphonamide, phenicols, and others), route of administration (enteral, parenteral, and others (inhalation, topical, etc.)), and distribution channel (hospital pharmacies, drug stores and retail pharmacies, and online pharmacies), across five major regions.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Website: https://www.factmr.com